Pfizer Shakes Up R&D Leadership, Streamlining Oncology Ahead Of Seagen Merger

 
• By Jessica Merrill
Exit door
William Pao is leaving Pfizer's R&D team • Source: Shutterstock

More from Leadership

More from Scrip